Latest from Kromek

Kromek receives order of $1.4m in medical imaging from Asia-based OEM customer in key SPECT market.

Kromek secures orders totalling over $1m in medical imaging. Repeat orders in key medical imaging target market of SPECT.

Pioneering work being championed here in the Northeast by Kromek, Newcastle-upon-Tyne Hospitals NHS Foundation Trust (“Newcastle Hospitals”), the University of Newcastle-upon-Tyne and University College London, made TV headlines this week after a further £2.5m of funding was awarded from the UK’s innovation agency, Innovate UK.

Innovate UK provides funds for two projects to advance low-dose molecular breast imaging solution.

Kromek Group plc (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, is pleased to announce that one of its key customers, Spectrum Dynamics Medical, has introduced the world’s first digital SPECT/CT scanner for higher energy imaging, using Kromek’s digital detectors.